Miguel Vizoso

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Azkanaz, Bernat Corominas-Murtra, Saskia I J Ellenbroek, Lotte Bruens, Anna T Webb, Dimitrios Laskaris, Koen C Oost, Simona J A Lafirenze, Karl Annusver, Hendrik A Messal, Sharif Iqbal, Dustin J Flanagan, David J Huels, Felipe Rojas-Rodríguez, Miguel Vizoso, Maria Kasper, Owen James Sansom, Hugo J G Snippert, Prisca Liberali, Benjamin David Simons, Pekka Katajisto, Edouard Hannezo, Jacco van Rheenen
Retrograde movements determine effective stem cell numbers in the intestine. Nature 607 (7919) (2022)
Andreia S Margarido, Rebeca Uceda-Castro, Kerstin Hahn, Roebi de Bruijn, Lennart Kester, Ingrid Hofland, Jeroen Lohuis, Danielle Seinstra, Annegien Broeks, Jos Jonkers, Marike L D Broekman, Pieter Wesseling, Claire Vennin, Miguel Vizoso, Jacco van Rheenen
Epithelial-to-Mesenchymal Transition Drives Invasiveness of Breast Cancer Brain Metastases. Cancers 14 (13) (2022)
Miguel Vizoso, Colin E J Pritchard, Lorenzo Bombardelli, Bram van den Broek, Paul Krimpenfort, Roderick L Beijersbergen, Kees Jalink, Jacco van Rheenen
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing. Nature communications 13 (1) (2022)
Miguel Vizoso, Jacco van Rheenen
Diverse transcriptional regulation and functional effects revealed by CRISPR/Cas9-directed epigenetic editing. Oncotarget 12 (17) (2021)
Jordi Alcaraz, Rafael Ikemori, Alejandro Llorente, Natalia Díaz-Valdivia, Noemí Reguart, Miguel Vizoso
Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities. Cancers 13 (15) (2021)